Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Annals of Hematology|July 25, 2018
Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failureKohei Hosokawa, Chiharu Sugimori, Ken Ishiyama, et al.Blood|August 31, 2006
Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH)Norimitsu Inoue, Tomohisa Izui-Sarumaru, Yoshiko Murakami, et al.International Journal of Hematology|July 8, 2018
Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in JapanYasutaka Ueda, Naoshi Obara, Yuji Yonemura, et al.International Journal of Hematology|February 1, 2018
Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in JapanYasutaka Ueda, Naoshi Obara, Yuji Yonemura, et al.Annals of Hematology|October 23, 2020
The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failureKohei Hosokawa, Ken Ishiyama, Toshiyuki Ikemoto, et al.European Journal of Haematology|June 15, 2023
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trialAlexander Röth, Satoshi Ichikawa, Yoshikazu Ito, et al.British Journal of Clinical Pharmacology|January 21, 2025
Pharmacokinetic characterization and exposure-response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuriaValérie Cosson, Rong Fu, Austin Kulasekararaj, et al.International Journal of Hematology|July 29, 2016
Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in JapanHaruhiko Ninomiya, Naoshi Obara, Shigeru Chiba, et al.The Journal of Clinical Investigation|August 21, 2019
Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammationBritta Höchsmann, Yoshiko Murakami, Makiko Osato, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2012
Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestineTakashi Kusu, Hisako Kayama, Makoto Kinoshita, et al.Pageof 8